Plasma kynurenine and related measures in tic disorder patients

  • Pieter J. Hoekstra
  • George M. Anderson
  • Pieter W. Troost
  • Cees G. M. Kallenberg
  • Ruud B. Minderaa
ORIGINAL CONTRIBUTION

Abstract

Objective

Increased plasma kynurenine has been reported in tic disorder patients, and this observation has been suggested to be indicative of immune dysregulation. In the present study, we examined plasma levels of kynurenine and related molecules in a group of tic disorder patients.

Methods

Plasma concentrations of tryptophan, kynurenine, cortisol, and neopterin were determined in Dutch tic disorder patients (N = 59), and healthy volunteers (N = 32). Group means were compared and age-controlled intra-individual correlations between tic severity and plasma levels of these molecules were examined.

Results

No significant differences were found between patient and control groups in plasma levels of tryptophan, kynurenine, and cortisol concentrations, nor in the kynurenine/tryptophan ratio. However, neopterin was significantly (= 0.035) higher in patients (mean = 5.13 nmol/l) than in controls (mean = 3.30 nmol/l). Plasma levels of these molecules did not correlate with tic severity, with the exception of tryptophan (r = −0.289, = 0.049). In patients, plasma neopterin correlated with kynurenine (r = 0.438, = 0.002); in healthy subjects, tryptophan correlated with kynurenine (r = 0.670, < 0.001).

Conclusion

While the observed elevation in plasma neopterin is consistent with immune activation in a subset of tic disorder patients, metabolism of tryptophan through the kynurenine pathway appears to be unaltered in tic disorder patients.

Keywords

tic disorders kynurenine tryptophan neopterin indoleamine 2,3-dioxygenase cortisol 

Abbreviations

IDO

indoleamine 2,3-dioxygenase

K/T ratio

kynurenine to tryptophan ratio

TDO

tryptophan 2,3-dioxygenase

References

  1. 1.
    American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Press, WashingtonGoogle Scholar
  2. 2.
    Bender DA, Njagi ENM, Danielian PS (1991) Comparison of tryptophan metabolism in vivo and in isolated hepatocytes from vitamin B6 deficient mice. Adv Exp Med Biol 294:359–368PubMedGoogle Scholar
  3. 3.
    Cardona F, Orefici G (2001) Group A streptococcal infections and tic disorders in an Italian pediatric population. J Pediatr 38(1):71–75Google Scholar
  4. 4.
    Church AJ, Dale RC, Lees AJ, Giovannoni G, Robertson MM (2003) Tourette’s syndrome: a cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry 74(5):602–607PubMedCrossRefGoogle Scholar
  5. 5.
    Comings DE (1990) Blood serotonin and tryptophan in Tourette syndrome. Am J Med Genet 36(4):418–430PubMedCrossRefGoogle Scholar
  6. 6.
    Dale RC, Candler PM, Church AJ, Wait R, Pocock JM, Giovannoni G (2006a) Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. J Neuroimmunol 172(1–2):187–197CrossRefGoogle Scholar
  7. 7.
    Dale RC, Church AJ, Candler PM, Chapman M, Martino D, Giovannoni G (2006b) Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 66(10):1612CrossRefGoogle Scholar
  8. 8.
    Dursun SM, Farrar G, Handley SL, Rickards H, Betts T, Corbett JA (1994) Elevated plasma kynurenine in Tourette syndrome. Mol Chem Neuropathol 21(1):55–60PubMedCrossRefGoogle Scholar
  9. 9.
    Gaynor CM, Rickards EHG, Kariyawasam SH, Sidey FM, Robertson MM, Corbett JA (1997) Increased plasma kynurenine in Tourette syndrome may be due to induction of IDO. J Psychopharmacol 11:A23Google Scholar
  10. 10.
    Gaynor CM, Handley SL (2001) Effects of nicotine on head-shakes and tryptophan metabolites. Psychopharmacology (Berl.) 153(3):327–333CrossRefGoogle Scholar
  11. 11.
    Heyes MP, Brew BJ, Saito K, Quearry BJ, Price RW, Lee K, Bhalla RB, Der M, Markey SP (1992) Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and β2 microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients. J Neuroimmunol 40(1):71–80PubMedCrossRefGoogle Scholar
  12. 12.
    Hoekstra PJ, Anderson GM, Limburg PC, Korf J, Kallenberg CG, Minderaa RB (2004a) Neurobiology and neuroimmunology of Tourette’s syndrome: an update. Cell Mol Life Sci 61(7–8):886–898Google Scholar
  13. 13.
    Hoekstra PJ, Steenhuis MP, Troost PW, Korf J, Kallenberg CG, Minderaa RB (2004b) Relative contribution of attention-deficit hyperactivity disorder, obsessive-compulsive disorder, and tic severity to social and behavioural problems in tic disorders. J Dev Behav Pediatr 25(4):272–279CrossRefGoogle Scholar
  14. 14.
    Hoekstra PJ, Minderaa RB (2005) Tic disorders and obsessive-compulsive disorder: is autoimmunity involved? Int Rev Psychiatry 17(6):497–502PubMedCrossRefGoogle Scholar
  15. 15.
    Kirvan CA, Swedo SE, Kurahara D, Cunningham MW (2006) Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham’s chorea. Autoimmunity 39(1):21–29PubMedCrossRefGoogle Scholar
  16. 16.
    Kurlan R (2004) The PANDAS hypothesis: losing its bite? Mov Disord 19(4):371–374PubMedCrossRefGoogle Scholar
  17. 17.
    Leckman JF, Anderson GM, Cohen DJ, Ort S, Harcherik DF, Hoder EL, Shaywitz BA (1984) Whole blood serotonin and tryptophan levels in Tourette’s disorder: effects of acute and chronic clonidine treatment. Life Sci 35(25):2497–2503PubMedCrossRefGoogle Scholar
  18. 18.
    Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ (1989) The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28(4):566–573PubMedCrossRefGoogle Scholar
  19. 19.
    Lepage N, McDonald N, Dallaire L, Lambert M (1997) Age-specific distribution of plasma amino acid concentrations in a healthy pediatric population. Clin Chem 43(12):2397–2402PubMedGoogle Scholar
  20. 20.
    Luo F, Leckman JF, Katsovich L, Findley D, Grantz H, Tucker DM, Lombroso PJ, King RA, Bessen DE (2004) Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics 113(6):e578–e585PubMedCrossRefGoogle Scholar
  21. 21.
    Maes M, Verkerk R, Bonaccorso S, Ombelet W, Bosmans E, Scharpe S (2002) Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation. Life Sci 71(16):1837–1848PubMedCrossRefGoogle Scholar
  22. 22.
    McCreary AC, Handley SL (1995) Kynurenine potentiates the DOI headshake in mice. J Psychopharmacol 9:68–69Google Scholar
  23. 23.
    Mell LK, Davis RL, Owens D (2005) Association between streptococcal infection and obsessive-compulsive disorder, Tourette’s syndrome, and tic disorder. Pediatrics 116(1):56–60PubMedCrossRefGoogle Scholar
  24. 24.
    Millner MM, Franthal W, Thalhammer GH, Berghold A, Aigner RM, Fuger GF, Reibnegger G (1998) Neopterin concentrations in cerebrospinal fluid and serum as an aid in differentiating central nervous system and peripheral infections in children. Clin Chem 44(1):161–167PubMedGoogle Scholar
  25. 25.
    Muller N, Riedel M, Straube A, Gunther W, Wilske B (2000) Increased anti-streptococcal antibodies in patients with Tourette’s syndrome. Psychiatry Res 94(1):43–49PubMedCrossRefGoogle Scholar
  26. 26.
    Murphy TK, Goodman WK, Ayoub EM, Voeller KK (2000) On defining Sydenham’s chorea: where do we draw the line? Biol Psychiatry 47(10):851–857PubMedCrossRefGoogle Scholar
  27. 27.
    Peterson BS, Leckman JF, Tucker D, Scahill L, Staib L, Zhang H, King R, Cohen DJ, Gore JC, Lombroso P (2000) Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive-compulsive, and attention deficit/hyperactivity disorders. Arch Gen Psychiatry 57(4):364–372PubMedCrossRefGoogle Scholar
  28. 28.
    Rickards H, Dursun SM, Farrar G, Betts T, Corbett JA, Handley SL (1996) Increased plasma kynurenine and its relationship to neopterin and tryptophan in Tourette’s syndrome. Psychol Med 26(4):857–862PubMedCrossRefGoogle Scholar
  29. 29.
    Schennach H, Murr C, Gachter E, Mayersbach P, Schonitzer D, Fuchs D (2002) Factors influencing serum neopterin concentrations in a population of blood donors. Clin Chem 48(4):643–645PubMedGoogle Scholar
  30. 30.
    Singer HS, Hong JJ, Yoon DY, Williams PN (2005) Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 65(11):1701–1717PubMedCrossRefGoogle Scholar
  31. 31.
    Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, Lougee L, Dow S, Zamkoff J, Dubbert BK (1998) Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 155(2):264–271PubMedGoogle Scholar
  32. 32.
    Waldrep DA (2002) Two cases of ADHD following GABHS infection: a PANDAS subgroup? J Am Acad Child Adolesc Psychiatry 41(11):1273–1274PubMedCrossRefGoogle Scholar
  33. 33.
    Walker KG, Lawrenson J, Wilmshurst JM (2005) Neuropsychiatric movement disorders following streptococcal infection. Dev Med Child Neurol 47(11):771–775PubMedCrossRefGoogle Scholar
  34. 34.
    Widner B, Werner ER, Schennach H, Wachter H, Fuchs D (1997) Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 43(12):2424–2426PubMedGoogle Scholar
  35. 35.
    Widner B, Laich A, Sperner-Unterweger B, Ledochowski M, Fuchs D (2002) Neopterin production, tryptophan degradation, and mental depression-What is the link? Brain, Behav Immun 16(5):590–595CrossRefGoogle Scholar
  36. 36.
    Yamazaki F, Kuroiwa T, Takikawa T, Kido R (1985) Human indoleamine 2,3 dioxygenase, its tissue distribution, and characterization of the placental enzyme. Biochem J 230(3):635–638PubMedGoogle Scholar
  37. 37.
    Yasui H, Takai K, Yoshida R, Hayaishi O (1986) Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxygenase: its possible occurrence in cancer patients. Proc Natl Acad Sci U S A 83(17):6622–6626PubMedCrossRefGoogle Scholar

Copyright information

© Steinkopff Verlag Darmstadt 2007

Authors and Affiliations

  • Pieter J. Hoekstra
    • 1
  • George M. Anderson
    • 2
  • Pieter W. Troost
    • 1
  • Cees G. M. Kallenberg
    • 3
  • Ruud B. Minderaa
    • 1
  1. 1.Department of PsychiatryUniversity Medical Center Groningen, University of GroningenGroningenThe Netherlands
  2. 2.Yale Child Study CenterNew HavenUSA
  3. 3.Department of Clinical ImmunologyUniversity Medical Center Groningen, University of GroningenGroningenThe Netherlands

Personalised recommendations